As of 2024-07-27, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.27 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -100.9%.
The range of the Relative Valuation is (0.00) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.3x | 0.1x |
| Forward P/E multiples | 0.1x - 0.3x | 0.1x |
| Fair Price | (0.00) - (0.01) | (0.00) |
| Upside | -100.7% - -102.8% | -100.9% |
| Date | P/E |
| 2024-07-26 | -9.18 |
| 2024-07-25 | -10.78 |
| 2024-07-24 | -8.98 |
| 2024-07-23 | -9.18 |
| 2024-07-22 | -9.18 |
| 2024-07-15 | -9.18 |
| 2024-07-12 | -9.18 |
| 2024-07-10 | -9.18 |
| 2024-07-05 | -9.38 |
| 2024-07-04 | -9.38 |
| 2024-07-03 | -9.38 |
| 2024-07-02 | -9.78 |
| 2024-06-27 | -9.38 |
| 2024-06-26 | -9.18 |
| 2024-06-25 | -9.18 |
| 2024-06-24 | -9.18 |
| 2024-06-21 | -9.58 |
| 2024-06-18 | -9.18 |
| 2024-06-14 | -9.58 |
| 2024-06-13 | -10.18 |
| 2024-06-11 | -10.38 |
| 2024-06-10 | -8.58 |
| 2024-06-07 | -10.78 |
| 2024-06-06 | -8.78 |
| 2024-06-04 | -9.58 |
| 2024-05-30 | -8.38 |
| 2024-05-28 | -8.18 |
| 2024-05-24 | -8.18 |
| 2024-05-22 | -8.38 |
| 2024-05-21 | -8.38 |
| 2024-05-14 | -8.38 |
| 2024-05-13 | -9.18 |
| 2024-05-10 | -9.18 |
| 2024-05-09 | -9.18 |
| 2024-05-08 | -9.18 |
| 2024-05-06 | -8.78 |
| 2024-05-03 | -8.18 |
| 2024-05-02 | -8.38 |
| 2024-05-01 | -8.78 |
| 2024-04-30 | -8.78 |
| 2024-04-29 | -8.78 |